Treatment administration
| LV5FU2-CDDP | Gemcitabine | p Value* | |
| Line 1 | Arm A | Arm B | |
| N = 102 | N = 100 | ||
| Patients with at least 1 administration | 101(99%) | 96 (96%) | 0.21 |
| Median duration of treatment in weeks (n = 96) | 5 (0.1–96) (n = 96) | 10 (1–64) (n = 93) | 0.0001 |
| Line 2 | Arm B | Arm A | |
| N = 100 | N = 102 | ||
| Patients with at least one administration | 55(55%) | 69 (68%) | 0.11 |
| Median duration of treatment in weeks | 4 (0.1–74) (n = 53) | 8 (1–21) (n = 63) | 0.044 |
↵* All two-sided Fisher exact tests or Wilcoxon rank-sum (Mann–Whitney) test.
LV5FU2-CDDP, 5-fluorouracil, folinic acid and cisplatin combination.